Abstract
Cancer might be thought of as a disease characterized by a deregulated cellular growth. Thus, it is not surprising that some of the molecular components of cell division cycle machinery are altered in human tumors. The cell cycle of all post-embryonic eukaryotic cells (including malignant cells) is divided into four phases, namely: G1 phase (period prior to DNA synthesis), S phase (period of DNA synthesis), G2 phase (period between DNA synthesis and mitosis) and M phase (mitosis). Collectively, G1, S and G2 are called interphase, the cell cycle period distinct from division of the nucleus (mitosis) and cytoplasm (cytokinesis) (Pardee, 1989; Desai et al., 1992). The length of the S, G2 and M phases is remarkably similar in many different cells, while the greatest variation is seen in the length of G1. At some point late in G1, called restriction or R point, a cell becomes committed to traverse the remainder of the cell cycle. Thus, variations in cell cycle time are mostly due to variations in the length of G1 up to the R point (Pardee, 1989; Desai et al., 1992).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Cairns P, Mao L, Merlo Lee DJA, Schwab D, Eby Y, Tokino K, van der Riet P, Blaugrund IE and Sidransky D (1994) Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 265: 415–417.
Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ and Kern SE (1994) Frequent somatic mutations and homozygous deletions of the p16 [MTS1] gene in pancreatic adenocarcinoma. Nat Genet 8: 27–32.
Chan FKM, Zhang J, Cheng L, Shapiro DN and Winoto A. (1995) Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16INK4. Mol Cell Biol 15: 2682–2688.
Della Ragione F, Mercurio C and Iolascon A (1995) Cell cycle regulation and human leukemias: the role of p16INK4 gene inactivation in the development of human acute lymphoblastic leukemia. Haematologica 80: 562–573.
Desai D, Gu Y and Morgan DO (1992) Activation of human cyclin-dependent kinases in vitro. Mol Biol Cell 3: 571–582.
Faienza MF, Della Ragione F, Basso G, Coppola B, Miraglia del Giudice Schettini F and Iolascon A (1996) p16INK4A gene homozygous deletions in human acute leukaemias with alterations of chromosome 9. Brit J Haematol 93: 632–636.
Guan K-L, Jenkins CW, Ki Y, Nichols MA, Wu X, O’Keefe CL, Matera AG and Xiong Y (1994) Growth suppression by p18, a p16INK4/MTS1 and p14INK4B/MT52-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 8: 2939–2952.
Hannon GJ and Beach D (1994) p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371: 257–260.
Hebert J, Cayuela JM, Berkeley J and Sigaux F (1994) Candidale tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias. Blood 8: 4036–4044.
Heichman KA and Roberts JM (1994) Rules to replicate by. Cell 79: 557–562.
Hirai H, Roussel MF, Kato J-Y, Ashmun RA and Sherr CJ (1995) Novel INK4 proteins, p19, p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol Cell Biol 15: 2672–2681.
Hunter T and Pines J (1994) Cyclins and Cancer II: Cyclin D and CDK inhibitors, come of age. Cell 79: 573–582.
Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Ally DS, Sheahan MD, Clark WH Jr, Tucker MA and Dracopoli NC (1994) Germline p16 mutations in familial melanoma. Nat Genet 8: 15–21.
Iolascon A, Miraglia Del Giudice E, Perrotta S, Russo GL, Oliva A, Mercurio C and Della Ragione F (1995a) p16INK4 gene deletions in childhood acute lymphoblastic leukemias. Leuk Res 19: 883–885.
Iolascon A, Faienza M, Coppola B, Della Ragione F, Santoro N and Schettini A (1995b) High frenquency of homozygous deletions of CDK4I gene in childhood acute lymphoblastic leukemia. Brit J Haematol 91: 647–651.
Iolascon A, Faienza MF, Coppola B, Della Ragione F, Schettini A and Biondi A (1995c) Homozygous deletions of cyclin-dependent kinase inhibibitor genes, p16INK4A and p18, in childhood T-cell lineage acute lymphoblastic leukemias. Leukemia 10: 255–260.
Iolascon A, Faienza MF, Coppola B, Rosolen A, Basso G, Della Ragione F and Schettini A (1996) Analysis of cyclin-dependent inhibitor genes (CDKN2A, CDKN2B and CDKN2C) in childhood rhabdomyosarcoma. Gene, Chromosome Cancer 15: 217–222.
Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavitgian SV, Stockert E, Day RS, Johnson BE and Skolnick MH (1994a) A cell cycle regulatory potentially involved in genesis of many tumor types. Science 264: 436–440.
Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y, Weaver-Feldhaus J, McClure M, Aitken J, F, Anderson DE, Bergman W, Frants R, Goldgar DE, Green A, MacLennan R, Martin NG, Mayer LJ, Youl P, Zone JJ, Skolknick MH and Cannon-Albright LA (1994b) Analysis of the p16 gene [CDKN2] as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 8: 22–26.
Kawamata N, Seriu T, Koeffler PH and Bartram CR (1996) Molecular analysis of the cyclin-dependent kinase inhibitor family: p]6 (CDKN2/MTS1/INK4A), p18 (INK4C) and p27(Kip1) genes in neuroblastoma. Cancer 77: 570–575.
King RW, Jackson PK and Kirschner MW (1994) Mitosis in transition. Cell 79: 563–571.
Liu Q, Neuhausen S, McClure M, Frye C, Weaver-Feldhaus J, Gruis NA, Eddington K, Allalunis-Turner MJ, Skolnick MH, Fujimura FK and Kamb A (1995) CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Oncogene 10: 1061–1067.
Mori T, Miura K, Aoki T, Nishihira T, Mori S and Nakamura Y (1994) Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 54: 3396–3397.
Nakamaki T, Kawamata N, Schwaller J, Tobler A, Fey M, Pakkala S, Lee YY, Kim BK, Fukuchi K, Tsuruoka N, Kahan J, Miljer CW and Koeffler HP (1995) Structural integrity of the cyclin-dependent kinase inhibitor genes, p15, p16 and p18 in myeloid leukaemias. Brit J Haematol 91: 139–149.
Nobori T, Miura K, Wu A, Luis K, Takabashi K and Carson DA (1994) Deletion of the cyclin-dependent kinase 4 inhibitor gene in multiple human cancers. Nature 368: 753–756.
Nurse P (1994) Ordering S phase and M phase in the cell cycle. Cell 79: 547–550.
Ogawa S, Hirano N, Sato N, Takahashi T, Hangaishi A, Tanaka K, Kurokawa M, Tanaka T, Mitani K, Yazaki Y and Hirai H (1994) Homozygous loss of cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias. Blood 84: 2431–2435.
Okamoto A, Demetrick DJ, Spillare EA, Hagiwara K, Hussain SP, Bennett WP, Forrester K, Gerwin B, Serrano M, Beach DH and Harris CC (1994) Mutations and altered expression of p16INK4A in human cancer. Proc Natl Acad Sci USA 91: 11045–11049.
Okamoto A, Hussain SP, Hagiwara K, Spillare EA, Rusin MR, Demetrick DJ, Serrano M, Hannon GJ, Shiseki M, Zariwala M, Xiong Y, Beach DH, Yokata J and Harris CC (1995) Mutations in the p16INK4A/MTS1 and p15INK4B/MTS4 and p18 genes in primary and metastatic lung cancer. Cancer Res 55: 1448–1451.
Pardee AB (1989) G1 events and regulation of cell proliferation. Science 246: 603–608.
Quesnel B, Preudhomme C, Philippe N, Vanrumbeke M, Dervite I, Lai JL, Bauters F, Watel E and Fenaux P (1995) p16 gene homozygous deletions in acute lymphoblastic leukemia. Blood 85: 657–663.
Schmidt EE, Ichimura K, Reifenberger G and Collins VP (1994) CDKN2 (p16: MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastoma. Cancer Res 54: 6321–6324.
Serra A, Gottardi E, Della Ragione F, Saglio G and Iolascon A (1995) Involvement of the cyclin-dependent kinase-4 inhibitor (CDKN2) gene in the pathogenesis of lymphoid blast crisis of chronic myelogenous leukemias. Brit J Haematol 91: 625–629.
Serrano M, Harmon GJ and Beach D (1993) A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 266: 122–6.
Sherr CJ (1994) G1 phase progression: cycling on cue. Cell 79: 551–5.
Solomon MJ, Lee T and Kirschner MW (1992) Role of phosphorylation in p34CDC2 activation. Mol Biol Cell 3:12–27.
Strauss M, Lukas J and Bartek J (1995) Unrestricted cell cycling and cancer. Nature Medicine 1:1245–1246.
Walker DG, Duan W, Popovic EA, Kaye AH, Tomlinson FH and Lavin M (1995) Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytoma. Cancer Res 55: 20–25.
Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81: 323–330.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Basel AG
About this chapter
Cite this chapter
Della Ragione, F. et al. (1998). Alteration of cell division cycle regulation in human cancers: The role of CDKN2A gene. In: Bannasch, P., Kanduc, D., Papa, S., Tager, J.M. (eds) Cell Growth and Oncogenesis. Molecular and Cell Biology Updates. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8950-6_10
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8950-6_10
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9841-6
Online ISBN: 978-3-0348-8950-6
eBook Packages: Springer Book Archive